Notable
ALTO-100 in Bipolar Disorder With Depression (BD-D)
Primary completion pushed from Aug 2026 to Sep 2027
Also in this update: Trial sites expanded: 27 → 68 locations; Study completion pushed from Oct 2026 to Oct 2027
Alto NeurosciencePhase 2 NCT06656416 Registry history of NCT06656416 on ClinicalTrials.gov (opens the registry)